ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed May 12, 2025 · 10-Q · 42 days after period end · 0001641172-25-009724
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$2.26M | -$2.83M | -$3.54M | -$720.01K |
| EPS Diluted | -$0.73 | -$4.53 | -$135.88 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end
